High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study
NCT00286000 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2007-12-28
Summary
A multicentre phase II study to evaluate the results of high dose simplified folfiri in advanced colorectal cancer
Conditions
- Advanced Colorectal Cancer
Interventions
- DRUG
-
Administration of high dose simplified folfiri
Sponsors & Collaborators
-
University Hospital, Ghent
lead OTHER
Principal Investigators
-
Marc Peeters, MD, PhD · University Hospital, Ghent
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
- Completion
- 2005-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen
NCT03279289 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms
NCT02970916 ·Status: COMPLETED ·Phase: PHASE2
-
Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer
NCT02849106 ·Status: COMPLETED ·Phase: NA
-
A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases
NCT01260415 ·Status: COMPLETED ·Phase: PHASE2
-
Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer
NCT06197425 ·Status: RECRUITING ·Phase: PHASE3
-
Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
NCT00126256 ·Status: COMPLETED ·Phase: PHASE3
-
Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer
NCT01060007 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3)
NCT03795311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
NCT01858662 ·Status: TERMINATED ·Phase: PHASE2
-
Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study
NCT06575127 ·Status: RECRUITING ·Phase: PHASE2
-
First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis
NCT01674309 ·Status: COMPLETED ·Phase: PHASE2
-
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
NCT00075595 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer
NCT00286130 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients
NCT01030042 ·Status: COMPLETED ·Phase: PHASE3
-
Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
NCT02456714 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery
NCT00265811 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
NCT00005979 ·Status: COMPLETED ·Phase: PHASE3
-
FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer
NCT05018182 ·Status: UNKNOWN ·Phase: PHASE2
-
lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients
NCT04735900 ·Status: UNKNOWN ·Phase: NA
-
Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy
NCT01378143 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)
NCT01039506 ·Status: COMPLETED
-
A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients
NCT00454116 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
NCT00320320 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
NCT05194878 ·Status: RECRUITING ·Phase: PHASE3
-
Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00559741 ·Status: COMPLETED ·Phase: PHASE2